1. Home
  2. BIIB vs IRM Comparison

BIIB vs IRM Comparison

Compare BIIB & IRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biogen Inc.

BIIB

Biogen Inc.

N/A

Current Price

$249.28

Market Cap

34.5B

Sector

Health Care

ML Signal

N/A

Logo Iron Mountain Incorporated

IRM

Iron Mountain Incorporated

N/A

Current Price

$110.63

Market Cap

34.1B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
BIIB
IRM
Founded
1978
1951
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
34.5B
34.1B
IPO Year
1996
1997

Fundamental Metrics

Financial Performance
Metric
BIIB
IRM
Price
$249.28
$110.63
Analyst Decision
Buy
Buy
Analyst Count
36
12
Target Price
★ $268.26
$138.73
AVG Volume (30 Days)
1.1M
★ 1.4M
Earning Date
10-28-2026
11-05-2026
Dividend Yield
N/A
★ 3.55%
EPS Growth
N/A
★ N/A
EPS
★ 2.66
1.23
Revenue
★ $9,890,600,000.00
$4,491,531,000.00
Revenue This Year
$6.92
$16.09
Revenue Next Year
$1.91
$9.13
P/E Ratio
$94.29
★ $90.91
Revenue Growth
2.22
★ 8.30
52 Week Low
$160.36
$77.77
52 Week High
$261.00
$134.68

Technical Indicators

Market Signals
Indicator
BIIB
IRM
Relative Strength Index (RSI) 54.04 45.97
Support Level $240.00 $107.58
Resistance Level $259.89 $118.53
Average True Range (ATR) 7.29 3.75
MACD -1.09 -0.07
Stochastic Oscillator 43.79 47.54

Price Performance

Historical Comparison
BIIB
IRM

About BIIB Biogen Inc.

Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (19% of total in 2025), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).

About IRM Iron Mountain Incorporated

Iron Mountain Inc is an information management services provider organized and operated as a real estate investment trust. The company offers solutions to its clients to address their information management, digital transformation, information security, data center, and asset lifecycle management (ALM) needs. Its customers come from various industries, including commercial, legal, financial, healthcare, technology, etc. The company has two reportable segments: Global Records and Information Management (Global RIM) and Global Data Center. Maximum revenue is generated from the Global RIM segment, which offers data and records management, secure shredding, consumer storage, and other related services. Geographically, the company generates maximum revenue from the United States.

Share on Social Networks: